Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Some people are genetically wired to resist Alzheimer's — and it has nothing to do with their genetic risk for the disease. Researchers developed a Polygenic Resilience Score (PReS) that predicts how long someone can stay dementia-free, regardless of APOE4 status. The catch? Vascular health is the key gatekeeper — untreated cardiovascular risk can wipe out the protective effect entirely.
Some people carry Alzheimer's pathology for years without converting to dementia — and now researchers think they know why. Scientists at Weill Cornell Medicine developed a Polygenic Resilience Score (PReS) using brain MRI phenotypes and whole genome sequencing, identifying 3,343 genetic variants tied to dementia resilience. Crucially, this resilience score is statistically independent of genetic risk scores — meaning being resilient isn't just the absence of risk; it's a separate biological phenomenon.
The protective effect is real and meaningful: patients with higher PReS had a median time to dementia conversion of 11.8 years, compared to just 6.1 years for those with lower PReS. The benefit held across both APOE4 carriers and non-carriers. But there's a major caveat — vascular health acts as a gatekeeper. The protective effect of PReS was strongest in patients with treated cardiovascular risk (statin or antihypertensive users) and was essentially nullified in those with untreated cardiovascular disease.
Key Takeaways:
Why it matters: This research reframes Alzheimer's prevention — it's not just about reducing risk, but about actively preserving resilience. And since vascular health modulates that resilience, managing blood pressure and cholesterol could be one of the most actionable tools clinicians have to delay dementia onset.